MedicarePartD.guide

A non-government resource built from CMS public data

Hadlima on SilverScript Choice (S5601-036)

adalimumab-bwwd

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 44.8 per 365 days.

$638.38
Patient pays / month, after deductible
$1,099.63
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

HADLIMA 40 mg/.8mL Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,553.50 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
HADLIMA 40 mg/.8mL Solution5$676.76PA · 44.8 per 365 days
HADLIMA 40 mg/.8mL Solution5$638.38PA · 44.8 per 365 days
HADLIMA 40 mg/.4mL Solution5$676.76PA · 22.4 per 365 days
HADLIMA 40 mg/.4mL Solution5$638.38PA · 22.4 per 365 days

Other TNF blockers on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-036